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Abstract: Introduction: The Blink Reflex Test (BRT) is a neurophysiological examination used for evaluation of brain-
stem reflex circuits. MRI is the most precise modality for evaluation of MS lesion anatomy. Our study objective was to 
investigate how the functional results of the neurophysiological BRT relate to the anatomy of MS lesions in routine MRI 
studies.  
Methods: 65 MS patients underwent the BRT within 2 months of a brain MRI showing demyelinating lesions.  
Results: The overall sensitivity of the BRT was 90.8%, while in patients with at least one brainstem lesion and no brain-
stem lesions it was 91.4% and 90%, respectively.  
Discussion: The presence of brainstem lesions does not significantly affect BRT sensitivity. This points to the influence of 
supratentorial MS lesions on the BRT. Gender, age, disease duration, type of MS, acuteness of an MS event and whether 
MS diagnosis was recent or not were not variables affecting the results. 
Keywords: Blink Reflex Test, Multiple Sclerosis, MRI Brain, Supratentorial Lesions, Brainstem. 
INTRODUCTION 
  The Blink Reflex Test (BRT) [1-3] is a neurophysiologi-
cal examination in which unilateral electrical stimulation of 
the nerve trunks of the supraorbital branches of the trigemi-
nal nerve in the forehead produces the afferent volley of a 
reflex, the efferent loop of which leads via the facial nerves 
to bilateral contraction of the orbicularis oculi muscles. 
Though it has some similarity to the clinical corneal reflex in 
which stimulation is applied to the nerve endings of the tri-
geminal nerve in the cornea, differences have been described 
[4,5]. The BRT normally produces two responses: an early 
(8-13 ms) unilateral R1 and a late (23-44 ms) bilateral R2. 
The R1 response is synchronous and does not habituate [5-8] 
since it is oligosynaptic [9]. It involves the main sensory 
nucleus of V [4,5,10,11] in the lateral midpontine and lower 
pontine regions and the ipsilateral facial nucleus (more spe-
cifically, the intermediate subnucleus [5,12-14]). The R2 
response is asynchronous because its central loop consists of 
a polysynaptic chain [4,5,15,16] with fibers 1) descending in 
the nucleus of the spinal tract of V from the pons to the cau-
dal medulla before ascending ipsilaterally to reach the facial 
nucleus and produce the ipsilateral R2 response and also 2)  
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crossing at the caudal medullary level to ascend contralater-
ally within the lateral propriobulbar system of the reticular 
formation, reaching the contralateral facial nucleus and pro-
ducing the contralateral R2 response. 
  Prior to introduction of MRI studies in neurology, the 
BRT was one of the diagnostic methods used in conjunction 
with clinical and other ancillary tests to diagnose MS. As the 
superior sensitivity of MRI studies was established, the use 
of the BRT was reduced in clinical practice, as were all other 
electrodiagnostic tests. In this study, we set out to investigate 
how the functional results of the BRT relate to the anatomy 
of MS lesions imaged in routine MRI studies. 
MATERIALS AND METHODOLOGY 
Participants 
  The patients examined in this prospective cohort were 
derived from our Neurology Clinic. One of the authors se-
lected them based on their meeting the McDonald criteria 
[17] for diagnosis of definite MS. The patients selected were 
out of a random pool of MS patients showing up in the Neu-
rology Clinic in the period allocated to testing (regular 
check-ups, relapses, de novo cases). Informed consent was 
requested and provided by all of them. The author perform-
ing the BRT was blinded as to the brain MRI results of the 
patients examined until after the collection of all data. We 
examined individuals who had just been diagnosed with MS, 
as well as patients who already carried the diagnosis. Purely 
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clinical presence of a normal or abnormal corneal reflex was 
not considered since it is not exactly the same as the blink 
reflex as far as the type of receptors and reflex circuit in-
volved are concerned [4,5]. Furthermore, the symptoms and 
clinical findings of the patients, whether suggesting brain-
stem involvement or not, were not taken into consideration 
for reasons explained in a later section. Sixty-five patients 
were examined (44 women and 21 men). Their ages varied 
from 17-71 years. Of these 65, 38/65 (58.5%) were under 40, 
while 27/65 (41.5%) were aged over 40. Based on the de-
tailed history of disease onset of all patients, their disease 
duration was estimated and found to be under 3 years in 
36/65 (55.4%) and over 3 years in 29/65 (44.6%). Based on 
their clinical type of MS, 45/65 (69.2%) patients had Relaps-
ing-Remitting MS (RRMS), 13/65 (20%) had Secondary 
Progressive MS (SPMS) and 7/65 (10.8%) had Progressive-
Relapsing MS (PRMS). In 40/65 (61.5%) the BRT was per-
formed within 1 week of the onset of diagnosis of MS [13/65 
(20%) patients] or of a clinical MS relapse [22/65 (33.8%) 
RRMS patients and 5/65 (7.7%) PRMS] and before steroids 
or any other treatment was given, while in 25/65 (38.5%) the 
timing of performance of the BRT was not related to a recent 
clinical MS event. Definite MS was just diagnosed (and in 
retrospect confirmed) in 13/65 (20%) of patients examined 
(no treatment had been initiated at the time of performance 
of the BRT), while in 52/65 (80%) the diagnosis had already 
been established.  
Radiological Criteria and Patient Groups 
  MRI exams used for the study were performed a) as part 
of the diagnosis in de novo MS patients (13/65), b) within 1 
week of clinical relapse and BRT performance in 22/65 pa-
tients with established RRMS and in 5/65 patients with 
PRMS and c) within 2 months of the BRT in the 13/65 pa-
tients with SPMS, 10/65 patients with RRMS and 2/65 pa-
tients with PRMS who had no recent clinical MS event. This 
time frame of 2 months was chosen based on knowledge of 
temporal evolution of gadolinium enhancement of lesions on 
MRI. The results of MRI exams were not known to the per-
son performing the BRT at the time of testing. The criteria of 
the International Consortium of MS centers [18] were used. 
MR imaging was performed on a Phillips Intera 1.5 T scan-
ner with a standard head coil and included the following 
pulse sequences: 1) 3 plane scout set up axial sections 
through the subcallosal line, 2) Sagittal fast FLAIR, 3) Axial 
FSE PD/T2 (TE 30/80), 4) Axial Fast FLAIR, 5) Axial pre-
gadolinium T1 weighted images, 6) Axial post gadolinium 
T1 weighted images obtained 5 minutes after the injection of 
0.1 mmole/kg of gadolinium based contrast agent. The axial 
slices were obtained with a section thickness of 3 mm with 
no intersection gap when feasible. The findings of each MRI 
exam were analyzed and reviewed in order to determine: 1) 
whether there was at least one brainstem lesion, 2) if there 
was a lesion in the brainstem, whether it showed gadolinium 
enhancement, 3) if there was a lesion in the brainstem, 
whether it was in the medulla, the pons or the midbrain, 4) 
whether any of the other lesions in the cerebral hemispheres 
showed gadolinium enhancement. Based on their brain MRI 
findings, the 65 MS patients examined were classified in the 
following categories: 1) 22 patients (33.9%) with no brain-
stem lesions and no gadolinium enhancement in any of the 
hemispheric lesions, 2) 8 patients (12.3%) with no brainstem 
lesions, but with gadolinium enhancement in at least one 
hemispheric lesion, 3) 21 patients (32.3%) with non-
enhancing brainstem lesions, whose other hemispheric le-
sions were also non-enhancing, 4) 9 patients (13.9%) with 
non-enhancing brainstem lesions and at least one enhancing 
hemispheric lesion, 5) 3 patients (4.6%) with enhancing le-
sions in the brainstem and the hemispheres, 6) 2 patients 
(3%) with enhancing lesions in the brainstem, but not in the 
hemispheres. 
Blink Reflex Test Setup and Protocol 
  The BRT was performed according to the standard meth-
ods suggested by the International Federation of Clinical 
Neurophysiology [19]. The Nihon-Koden, Neuropack- 
model was used for testing. All tests were performed by the 
same person. The patients were in supine position, in a re-
laxed state and with eyes open. A ground electrode was 
placed on the patients’ forehead or chin. The active record-
ing electrode was placed on the inferior orbital part of the 
orbicularis oculi, just lateral to the vertical line that may be 
drawn with the pupils in midposition. The reference record-
ing electrode was placed lateral to the lateral canthus of each 
eye. Recording electrodes were placed on both sides. The 
machine settings were as follows: sweep speed 10 
ms/division, sensitivity 100-200 μV/division, motor filter 
settings 10 Hz and 10 kHz. Facial nerve studies were ini-
tially performed for each patient to ensure that normal motor 
latency and amplitude could be obtained on each side and 
that there was no damage to the peripheral part of the effer-
ent loop of the reflex. All patients examined had normal fa-
cial nerve studies. The supraorbital branches of the trigemi-
nal nerve were stimulated on each side with a stimulus of 5-
25 mA intensity, 0.1 ms duration and no faster than 1/30s 
frequency. The stimulus intensity was increased by 5mA 
until a reliable response was obtained. Bilateral recordings 
were made simultaneously. In order to obtain both the short-
est R1 and R2 latency and an unambiguous response once 
each patient’s threshold stimulus intensity was obtained, 4-
10 responses were superimposed from each side and one was 
chosen (see discussion). 
Blink Reflex Test Interpretation 
  Twenty three normal subjects were examined (8 males, 
15 females, age 19-42) after informed consent was obtained. 
Abnormal latency values were established as follows: R1 
>13 ms, ipsilateral R2 >41 ms, contralateral R2 >44 ms. The 
values obtained are in accordance with published literature 
[1,2,5,13]. We considered responses to be abnormal when 1) 
they could not be elicited or 2) were delayed beyond the 
normal values. As previously described elsewhere 
[1,5,11,13], additional criteria utilized were: 3) unilateral 
delay of R1 >1.2 ms compared to other side, 4) side differ-
ences of R2 >5 ms between the ipsilateral and contralateral 
responses, obtained with unilateral stimulation, 5) side dif-
ferences of R2 >7 ms on a given side, obtained with right 
and left sided stimulation. 
Statistical Analysis 
  The sensitivity of the test in all categories and the respec-
tive 95% confidence interval (CI) was calculated. The asso-
ciation between BRT outcome and categorical variables was 
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RESULTS 
Test Results 
 Table  1, in its upper section, shows the BRT results of all 
patients. The R1 latency was abnormal in 26/65 (40%) pa-
tients. The ipsilateral R2 latency was abnormal in 35/65 
(53.8%). The contralateral R2 latency was abnormal in 34/65 
(52.3%) patients. The reason that the number of patients 
showing abnormalities of each parameter is not the sum of 
abnormalities found on each side is because the same patient 
often showed abnormalities on both sides.  
 Table  1, in its lower section, also shows the sensitivity of 
the additional criteria, obtained by calculations based on the 
BRT results recorded. It is worth mentioning that the addi-
tional criteria employed that are based on mathematical cal-
culations constituted the sole basis for considering the BRT 
as positive in only 4/65 (6.2%) patients. 
  The number of criteria used to define the BRT as positive 
is shown in Table 2. Even though the above described six 
criteria were used, the number of criteria that arises from 
bilateral evaluation of results is eleven. In the vast majority 
of patients, several criteria were met confirming the positiv-
ity of the BRT.  
Overall Sensitivity 
  The BRT was overall positive in 59/65 of patients with 
MS. Thus, the sensitivity of the test was Se=90.8% (95% CI: 
83.7-97.8). The test was negative in 6/65 patients [9.2% 
(95% CI: 2.2-16.3)]. 
Sensitivity in Patient Subpopulations, Based on MRI 
Data 
 Table  3 shows the sensitivity of the BRT for the different 
outcomes of brain MRI. Of the 65 patients examined, 35/65 
(53.9%) had at least one lesion in the brainstem on MRI, 
while 30/65 (46.1%) had no brainstem lesions. In the 35 pa-
tients with at least one brainstem lesion, the sensitivity of the 
BRT was Se=91.4% (95% CI: 82.2-100), while 8.6% (95% 
Table 1.  Blink Reflex Test Results 
 
Test Parameter  Number of Criteria  BRT
* Abnormality per side  BRT
* Abnormality in patients 
1) Left Stimulation  17/65 (26.2%) 
R1 Latency (All
†) 
2) Right Stimulation  18/65 (27.7%) 
26/65 (40%) 
3) Left Stimulation  20/65 (30.8%) 
R2 Ipsilateral Latency (All
†) 
4) Right Stimulation  22/65 (33.8%) 
35/65 (53.8%) 
5) Left Stimulation  24/65 (36.9%) 
R2 Contralateral Latency (All
†) 
6) Right Stimulation  25/65 (38.5%) 
34/65 (52.3%) 








Left Stimulation  12/35 (34.3%)
‡ 
R2 Ipsilateral Latency (BS
‡) 




Left Stimulation  15/35 (45.7%) 
R2 Contralateral Latency (BS
‡) 
Right Stimulation  17/35 (48.6%) 
22/35 (62.9%) 
ADDITIONAL CRITERIA       
Left / right R1 >1.2ms  7)    19/65 (29.2%) 
8) Left Stimulation  38/65 (58.5%) 
Ipsi- vs. Contra-lateral R2 >5ms 
9) Right Stimulation  34/65 (52.3%) 
48/65 (73.9%) 
10) Left R2 >7ms  28/65 (43.1%) 
Left&right stimulation R2 >7ms 
11) Right R2 > 7ms  33/65 (50.8%) 
46/65 (70.8%) 
*BRT: Blink Reflex Test. 
†All: All patients examined, regardless of brainstem involvement or not. 
‡BS: Brainstem involvement, regardless of concurrent hemispheric involvement. 
§Note: it is a pure numerical coincidence that that percentage of abnormalities of R1 and ipsilateral R2 latencies in the brainstem are the same, as the patients from whom they were 
derived were not.  
Table 2.  Number of Criteria Fulfilled for Considering the Blink Reflex Text as Abnormal 
 
Number of criteria fulfilled for  
abnormal BRT
* 
1 2 3 4 5 6 7 8 9  10  11 
Patient  number  8  10  6 5 4  10  4 7 2 2 1 
Patient percentage
† 13.6%  16.9%  10.2% 8.5%  6.8% 16.9% 6.8% 11.9%  3.4% 3.4% 1.7% 
*BRT: Blink Reflex Test. 
†Patient percentage: Patient number / 59 (59 patients had an abnormal BRT). Blink Reflex Test in MS  The Open Neurology Journal, 2010, Volume 4    95 
CI: 0-17.8) had a negative test. In the 30 patients with no 
brainstem lesions, the sensitivity of the BRT was Se=90% 
(95% CI: 79.3-100), while 10% (95% CI: 0-20.7%) had a 
negative test. 
  The number of patients studied in whom there was no 
gadolinium enhancement in any of the imaged lesions was 
43 and, in these patients, the sensitivity of the BRT was 
Se=93% (95% CI: 85.4-100). Twenty two patients had at 
least one gadolinium enhancing lesion anywhere in the brain, 
whether in the hemispheres or the brainstem, and the BRT 
sensitivity was Se=86.4% (95% CI: 72-100).  
  In 5 of the MS patients studied, there was gadolinium 
enhancement in at least one brainstem lesion, regardless of 
the presence or absence of gadolinium enhancement in other 
lesions in the cerebral hemispheres. In all these patients 
(100%), the BRT was positive. 
  The number of patients studied in whom there was gado-
linium enhancement only in cerebral hemispheric but not in 
brainstem lesions was 17, regardless of the presence of a 
non-enhancing lesion in the brainstem. The BRT sensitivity 
was Se=82.4% (95% CI: 64.2-100). 
Effect of Site of Brainstem Lesion 
  As mentioned above, brainstem lesions were present in 
35 of the MS patients examined. The majority had only one 
lesion, while some had more than one. Most involved in our 
random series of MS patients was the pons and 19/21 
(Se=90.5%, 95% C.I.: 78-100) patients with one or more 
pontine lesions had an abnormal BRT. Both the pons and the 
medulla were involved in 8 patients, all of whom had an ab-
normal BRT. The medulla alone was involved in just 2 pa-
tients, both of whom had an abnormal BRT. Of the 2 patients 
who had a solitary midbrain lesion, only one had an abnor-
mal BRT. A patient with lesions in the midbrain and medulla 
and another patient who had a lesion in all three divisions of 
the brainstem, both had an abnormal BRT. Table 4 shows the 
distribution of lesions within the brainstem and the associ-
ated BRT results. 
Table 3.  Sensitivity of the Blink Reflex Test for the Different Outcomes of Brain MRI 
 
MRI
* brain (gold standard) 


















Gadolinium enhancement, overall 




§ lesions  
(and hemispheric)  
5/5 
100%  Gadolinium enhancement, 
specifically 
only in hemispheric lesions 
14/17 
82.4% (64.2-100%) 
*MRI: Magnetic Resonance Imaging. 
†BRT: Blink Reflex Test. 
‡CI: Confidence Interval. 
§BS: Brainstem. 
Table 4.  Site of Brainstem Lesions and Blink Reflex Test Results 
 
BRT
† Results Number of patients 
MRI
* Brain Site of Brainstem Lesions 
Abnormal BRT  Normal BRT 
Pons (only)  19/21  2/21 
Pons + Medulla  8/8  0/8 
Medulla (only)  2/2  0/2 
Medulla + Midbrain  1/1  0/1 
Midbrain (only)  1/2  1/2 
Midbrain+Pons+Medulla 1/1  0/1 
TOTAL  32/35 (91.4%)  3/35 (8.6%) 
*MRI: Magnetic Resonance Imaging. 
†BRT: Blink Reflex Test. 96     The Open Neurology Journal, 2010, Volume 4  Mikropoulos et al. 
 Table  1, in its middle shaded region, shows the detailed 
BRT results in this subgroup of patients. Among the 35 MS 
patients in whom brainstem lesions were found in MRI, the 
R1 latency was abnormal in 16/35 (45.7%) patients. The 
ipsilateral R2 latency was abnormal in a different group of 
16/35 (45.7%) patients. The contralateral R2 latency was 
abnormal in 22/35 (62.9%). 
Effect of MRI Enhancement of Brainstem Lesion 
  As mentioned above, all 5 patients examined who had at 
least one enhancing brainstem lesion (regardless of the pres-
ence or absence of gadolinium enhancement in other lesions 
in the cerebral hemispheres) had an abnormal BRT. Of these 
patients, two had lesions only in the pons, two had lesions in 
the pons and the medulla and one had a lesion only in the 
medulla. Interestingly, the left and right R1 latencies were 
normal in all of these patients and subsequent revision of 
their MRIs showed that 3 out of 4 pontine lesions were in the 
upper pons (not in the mid- or lower pons, where R1 abnor-
malities have been localized to in the literature). The ipsilat-
eral R2 latencies were bilaterally abnormal in just 2 of the 
patients and, of note, their contralateral R2 latencies were 
bilaterally normal (both patients had pontine lesions; one 
also had a medullary lesion). The contralateral R2 latencies 
were abnormal in all 3 patients with a medullary lesion (of 
whom one also had a pontine lesion) and in 1 patient with a 
single pontine lesion. 
  Of the other 30 patients with a brainstem lesion that 
showed no gadolinium enhancement, 27 (Se=90%, 95% C.I.: 
79.3-100) had an abnormal BRT and 3 patients (Se=10%, 
95% C.I.: 0-20.7) had a normal BRT.  
Effect of Gender, Age, Disease Duration, Clinical Form 
of MS, Acute MS Event, Recent MS Diagnosis 
 Table  5 shows the association results between BRT out-
come and the demographic data of the patients examined. No 
association was found between the BRT outcome and 1) the 
gender [p=0.66], 2) age under and over 40 [p=0.99], 3) dis-
ease duration under and over 3 years [p=0.99], 4) clinical 
type of MS (RRMS, SPMS, PRMS) [p=0.63], 5) the pres-
ence of an acute MS clinical event (one week or less) before 
BRT testing (no treatment initiated before BRT) vs. not 
[p=0.99], 6) MS being a recent diagnosis (before any treat-
ment was provided to them) vs. being an already established 
diagnosis [p=0.59]. 
DISCUSSION 
BRT in MS 
  The first conclusion was that 90.8% of our patients, all of 
whom had an established diagnosis of MS and brain lesions, 
were found to have a positive BRT. A literature review re-
veals a relatively small number of studies concerning the use 
of the BRT in MS [13, 20-33]. Most of these were conducted 
before 1986 and the results applied to patients in whom the 
diagnosis had been established or presumed without the pos-
sibility of MRI correlation. The sensitivity of the BRT in 
these studies was 26-78%, but direct comparison with our 
study cannot be made. It has been suggested that the diver-
sity of sites of lesions within the brainstem is responsible for 
the diversity in responses between patients [34]. In a study of 
21 patients with a diagnosis of definite MS who did not have 
clinical symptoms or signs referable to the brainstem, the 
sensitivity of the test was only 40% [32]. MRI had been per-
formed in all of them, but the findings were not further ana-
lyzed. In a recent study published that has some similarity to 
ours in that MRI findings were considered, the BRT was 
positive in 75% of 40 patients with RRMS and 83.3% of 6 
patients with SPMS [33]. However, for reasons explained 
below, the principal aim of our study was not to investigate a 
possible correlation between the results of the BRT and 
clinical findings, but with imaging data provided by the rou-
tine MRI protocols that are widely used today. 
Table 5.  Association Results Between Blink Reflex Test Outcome and Demographic Data 
 
 BRT




male 95.2%  (20/21)  4.8%  Gender 
female 88.6%  (39/44)  11.4% 
0.66 
>40 92.6%  (25/27)  7.4% 
Age (years) 
40 89.5%  (34/38)  10.5% 
0.99 
>3 89.7%  (26/29) 10.3% 
Disease duration (years) 
3 91.7%  (33/36)  8.3% 
0.99 
RRMS
§ 88.9%  (40/45)  11.1% 
RPMS
§ 100%  (7/7)  0%  Clinical type of MS
‡ 
SPMS
§ 92.3%  (12/13)  7.7% 
0.63 
Yes 90%  (36/40)  10% 
Acute MS clinical event 
No 92%  (23/25)  8% 
0.99 
Yes 84.6%  (11/13)  15.4% 
New MS diagnosis 
No 92.3%  (48/52)  7.7% 
0.59 
*BRT: Blink Reflex Test. 
†Using the chi-squared test. 
‡MS: Multiple Sclerosis. 
§Clinical Types of MS: RRMS, Relapsing-Remitting; RPMS, Relapsing Progressive; SPMS, Secondary Progressive. Blink Reflex Test in MS  The Open Neurology Journal, 2010, Volume 4    97 
  It was surprising to find such a high sensitivity (90.8%) 
of BRT in our MS patients. In our study, the BRT was per-
formed by the same person who was unaware of the results 
of MRI exams, as to the presence of brainstem lesions or 
gadolinium enhancement. Statistical analysis clearly showed 
the validity of our results through different radiological and 
demographic variables, each variable involving groups of 
different patients. In addition, several criteria were used and 
were fulfilled in most patients in order to consider the BRT 
as positive (Table 2). If we had only considered abnormal 
latencies of R1, ipsilateral and contralateral R2 as criteria of 
positivity without including criteria involving mathematical 
calculations, the BRT would have been found positive in 
55/65 (Se=84.6%, 95% CI: 75.8-93.4) instead of 59/65 
(Se=90.8%, 95% CI: 83.7-97.8). This sensitivity would have 
been in the high range of that published by others, the vast 
majority of whom did not employ the additional criteria. 
Considering the mean latencies of R1 and R2 of each patient 
instead of choosing the most unambiguous trace with the 
shortest latency, as we did, may also have produced different 
results that would explain the diversity of findings reported 
in various studies. However, this data could not be retrieved 
when the testing was completed and the above results were 
obtained. It cannot be answered if this methodological dif-
ference can account for the discrepancy between our study 
and others, but future investigators planning to conduct simi-
lar studies should probably consider the mean latencies of 
R1 and R2 for each patient or even investigate whether the 
two different approaches significantly affect the results. Per-
haps part of the explanation lies in differences between cur-
rent and older machines used for electromyography. In the 
end, due to the study design differences and lack of more 
details on possible technical and interpretation differences of 
testing, we cannot adequately explain the discrepancy in 
sensitivity between our study and others. But after all, an 
adequate explanation for the wide variability in sensitivity 
reported in other existing studies (approximately 26-83.3%) 
has never been provided, given that all published data are 
supposed to have been derived by experienced investigators 
trying their best to adhere to similar testing protocols.  
Impact of Brainstem Demyelinating Lesions 
  The fact that consistency is noted between the overall 
sensitivity of the BRT (90.8%) and the sensitivity of this test 
in patients with (91.4%) and without (90%) lesions in the 
brainstem, suggests that the mere presence of imaged lesions 
in the brainstem on a conventional MRI does not have a sig-
nificant effect on the diagnostic value of the BRT. 
  A simplistic expectation in such a study would be that 
since the BRT is mediated mainly by the brainstem, a higher 
sensitivity should be revealed in patients with imaged brain-
stem pathology. However, an explanation for our results may 
lie in the importance of the influence of supratentorial le-
sions of the midbrain and hemispheres on the BRT, with 
both R1 and, especially, R2 waves known to be affected in 
patients with vascular lesions, mostly acute and isolated. 
Such influences on R1 [5,13,35,36] are considered to be 
more limited and acute than those of R2. Therefore, in pa-
tients with vascular lesions, an isolated abnormal R1 re-
sponse is generally thought to strongly correlate to ipsilateral 
lateral midpontine or lower pontine lesions [1,4,5,10-13]. 
The same does not apply with the R2 responses in which 
supratentorial influences of lesions in the midbrain and 
hemispheres, especially the lower postcentral region, affect 
the results to a degree that does not allow R2 abnormalities 
to reliably be attributed to bulbar lesions [1,5,15,16,35,37-
42]. This may explain why R2 abnormalities were more fre-
quently encountered in our study than R1 abnormalities, 
whether examining the results of all patients or just the re-
sults of patients with imaged brainstem pathology (Table 2). 
The finding that the percentage of R1 and R2 abnormalities 
was higher in the group of patients with imaged brainstem 
pathology compared to all patients in the study may still be 
in accordance with the fact that the main anatomic circuitry 
involved in BRT is in the brainstem. The above results may 
finally suggest that MRI may reflect brainstem involvement 
more appropriately than BRT in MS. Based on our findings 
and on the presumption that in MS the pathology is not as 
limited and the clinical symptomatology is not necessarily as 
well-defined as that of a patient with an acute brainstem in-
farction (especially one who is more qualified to be studied 
with BRT localization studies based on the absence of multi-
infarct disease), we do not think that extracting results about 
the localizing value of R1 and R2 from patients with MS and 
acute brainstem lesions is similar. Furthermore, even though 
studies of patients with brainstem infarctions have shown an 
abnormal R1 response to have a strong localizing value 
pointing to ipsilateral midpontine to lower pontine lesions, a 
correlative MRI study in patients with brainstem infarctions 
failed to confirm this [43]. The above data suggest that re-
search studies of the blink reflex involving heterogeneous 
groups of diseases should possibly be avoided. 
  Another explanation for our findings may lie in the MRI 
techniques used today for imaging MS lesions. In our study, 
standard MRI techniques were accepted for the imaging of 
lesions in the brainstem and hemispheres. It is possible that 
as some newer imaging techniques such as diffusion tensor 
imaging (fractional anisotropy, tractography), magnetization 
transfer ratio (MTR) imaging, dual inversion recovery imag-
ing, MR spectroscopy, functional MRI and others may be 
more widely employed and increase the sensitivity of MRIs 
of the brain, there will be better correlation of imaging data 
with neurophysiological or clinical findings. 
  One may wonder about the correlation of clinical brain-
stem signs to BRT results. After considerable thought, the 
symptoms and clinical findings, whether suggesting brain-
stem involvement or not, were not taken into consideration. 
The reason for this choice is not only that symptoms and 
clinical findings attributed solely to brainstem involvement 
constitute a minority, especially at onset, but more impor-
tantly that the majority of ophthalmokinetic, motor and sen-
sory symptoms - especially as time from diagnosis goes by - 
may also be caused by lesions anywhere along the complex 
tracts [44] that carry or influence these modalities supraten-
torially. In our opinion, this often makes the distinction of 
which of many lesions produces these symptoms in MS am-
biguous and often too subjective for statistical analysis. The 
fact that studies in patients with MS have shown a frequent 
association of internuclear ophthalmoplegia with R1 abnor-
malities (that is still limited to 1/3 of these patients) [10,11] 
does not mean that one can draw conclusions about more 
subtle or rare ophthalmokinetic abnormalities and their anat-
omic correlates, especially given the usual dissemination of 
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Impact of Gadolinium Enhancement on MRI 
  As shown in Table 3, even though one might expect a 
higher BRT sensitivity in patients whose MRI showed gado-
linium enhancement as an indication of more active disease, 
this was not found to be true. It is interesting, however, that 
all five patients with at least one gadolinium enhancing le-
sion in the brainstem had a positive BRT. This result does 
not have the desired statistical significance due to the small 
number of patients, but represents what a clinician would 
inherently expect by correlating neurophysiology with neu-
roanatomy. 
Impact of Patient Demographic and Clinical Parameters 
  The BRT results were not affected by the gender of the 
patients, whether their age was under or over 40, whether the 
diagnosis of MS was recent or not, whether an acute MS 
event had occurred, whether disease duration was less or 
more than 3 years, and whether they were currently classi-
fied in one or other type of MS. These findings are interest-
ing considering that younger patients are generally known to 
have more active disease, with relapses and remissions pre-
dominating over slowly progressive symptoms. The course 
of the disease is similarly more active in the first years, with 
most patients following the relapsing-remitting pattern of 
disease progression. Enhancement frequency on MRI has 
been shown to decrease with increasing age in relapsing-
remitting MS [45]. In agreement with our findings, a study 
[34] of 33 patients showed no dependence of alterations to 
the BRT on the duration of illness. 
  The effect of therapies used for MS on R results can-
not be adequately assessed in a study of this design. At one 
time or another, 80% of our study participants have received 
immune-modifying therapy, with most being actively treated 
with one or the other medication. The only ones not to have 
received any treatment were the 20% of patients included in 
the study with de novo MS diagnosis. As mentioned above, 
no significant statistical correlation (p=0.59) was found be-
tween the two groups. 
CONCLUSION 
  MRI testing of the brain is undoubtedly the diagnostic 
modality of choice for diagnosing patients with clinical evi-
dence of MS and sometimes for follow-up. Electrodiagnostic 
neurophysiological testing is often used for following up 
patients, as its role in establishing an MS diagnosis has be-
come more limited. The most important finding in this study 
is that the sensitivity of the BRT is consistent in patients 
with and without imaged demyelinating lesions in the brain-
stem. First of all, this suggests that studies of the blink reflex 
involving heterogeneous groups of diseases (i.e MS, vascular 
infarctions) should be avoided. The notion of the BRT repre-
senting a purely brainstem reflex is again challenged as its 
long-known, but often forgotten, supratentorial influences 
resurface. Most other studies have focused on such influ-
ences in vascular patients, not MS. However, unlike the case 
with isolated vascular lesions, the multiplicity in number and 
the diversity in pathophysiological stage of demyelinating 
lesions has not allowed any investigator to attempt a more 
precise correlation of supratentorial lesions with the neuro-
physiology of the blink reflex. At present, brain MRI may 
reflect brainstem involvement more appropriately than BRT, 
regardless of the degree of correlation of each study modal-
ity to the clinical picture. Still, newer MRI techniques that 
are not yet widely used in the community or others yet to be 
developed may demonstrate what may now be “subimage-
able” disease in the brainstem of MS patients. Different cor-
relations will then be possible between BRT results, MRI 
findings and even clinical symptoms or signs. Until then, the 
need to adequately evaluate the results obtained in the con-
text of each individual patient remains as strong as ever. 
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